Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

6 Results Found

AHA Center for Health Innovation Market Scan
Public

Digital Health Funding Surges in Q1, with AI Leading the Way

Digital health funding, particularly in artificial intelligence (AI) companies, surged 47% in Q1 over the previous quarter, even as deal volume slipped 9%, according to a recent CB Insights report.
AHA Center for Health Innovation Market Scan
Public

4 Signs That This Might Be a Stronger Year for Digital Health Funding

For 2025, a rebound may be in store for investments in digital health startups, according to a recent survey report from Summit Health Advisors.
AHA Center for Health Innovation Market Scan

4 Ways Strategic Partnerships Will Transform Care Delivery

During the recent HLTH conference, health care leaders from hospitals and health systems, digital health companies and others shared how they are teaming up to further accelerate rapid innovation and transformation in care delivery.
AHA Center for Health Innovation Market Scan

Verizon Accelerator Program Targets 7 Startups Addressing Health Equity

Seven organizations recently completed the third cohort of Verizon’s Forward for Good Accelerator, which is focused on scaling solutions that address barriers to health access and high-quality care.
AHA Center for Health Innovation Market Scan

Health System Venture Funds Place Their Bets on Innovation

With ever-increasing frequency, hospitals and health systems are establishing or expanding venture funds in search of the next startup that could revolutionize health care. Consider some recent transactions.
AHA Center for Health Innovation Market Scan

Three Takeaways from the J.P. Morgan Health Care Conference

At last week’s J.P. Morgan Health Care Conference, the investment banking giant’s health care arm Morgan Health made some of the biggest news amid developments from health care startups, providers, tech developers, biotech and pharma firms.